Gladstone NOW: The Campaign Join Us on the Journey ✕
256 - 270 of 1505 Results Clear All
Learn more about these indigenous scientists who’ve made an impact on their fields
Communications Diversity
Bloomberg—Katerina Akassoglou, a neurovascular brain immunologist at Gladstone, and her team discovered that beyond serving as the virus’s “key” to enter cells, spike binds with a blood clotting factor called fibrinogen, causing a cascade of events that contribute to the neurological symptoms of long COVID.
COVID-19 Akassoglou Lab
New York Post—Top health researchers from the Murdoch Children’s Research Institute in Australia have teamed with those from Gladstone Institutes in San Francisco on a new program to develop cutting-edge technologies to treat the underlying causes of childhood heart disease more effectively.
Institutional News Cardiovascular Disease
Researchers discovered that the presence of autoantibodies in the nose can help fight off the virus more effectively.
Research (Publication) COVID-19 Infectious Disease Roan Lab
Gladstone's Magnus Hoffmann seeks to advance a new generation of more effective vaccines, improved drug delivery methods, and a greater overall understanding of vaccine-induced immune responses.
COVID-19 Data Science and Biotechnology Infectious Disease
Transplanting human neurons into mouse brains reveals disease-causing interactions between the APOE4 protein and immune cells.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab
A new collaboration between Gladstone Institutes and Murdoch Children’s Research Institute to accelerate life-saving therapies for children affected by heart disease.
Institutional News Cardiovascular Disease
The new findings have implications for developing immune therapies that target heart disease and chronic conditions in other organs.
News Release Research (Publication) Heart Failure Cardiovascular Disease Alexanian Lab Srivastava Lab
Gage has reshaped our understanding of stem cells in the adult brain with landmark discoveries that may contribute to the development of new or better therapies for neurological disorders.
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
Gladstone scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.
News Release Research (Publication) Alzheimer’s Disease Dementia Multiple Sclerosis Parkinson’s Disease Neurological Disease Akassoglou Lab
Arc Institute—Gladstone investigator Isha Jain joins Arc Institute's new cohort of core investigators to drive visionary research into complex human disease. She will receive unrestricted funding to advance her research on how the body senses and responds to variations in oxygen levels and vitamins.
Grants Jain Lab
Yanilka Soto-Muñiz, a graduate student in Ken Nakamura’s lab, shares her journey from Puerto Rico to neuroscience research, highlighting her inspiration from women in science, her resilience after Hurricane Maria, and her dedication to understanding neurological diseases
Profile Neurological Disease Nakamura Lab
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Infectious Disease Ott Lab
San Francisco Business Times—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, is selected as one of the Most Influential Women in Bay Area Business 2024 for her contributions as a thought leader driving innovation in AI and her mentorship of future biomedical scientists.
Awards Pollard Lab
Hear about the “Strengths-Based Model of Neurodiversity” and how it can help neurodiverse individuals be successful in finding employment and in maximizing their professional potential
Communications Diversity
